Bandaríkin - enska - NLM (National Library of Medicine)

rebel distributors corp - albuterol (unii: qf8svz843e) (albuterol - unii:qf8svz843e) - albuterol 90 ug - albuterol inhalation aerosol is indicated for the prevention and relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease, and for the prevention of exercise induced bronchospasm in patients 4 years of age and older. albuterol inhalation aerosol can be used with or without concomitant steroid therapy. albuterol inhalation aerosol is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. before using your albuterol inhalation aerosol, read complete instructions carefully. children should use albuterol inhalation aerosol under adult supervision, as instructed by the patient's doctor. the blue adapter supplied with albuterol inhalation aerosol should not be used with any other product canisters, and adapters from other products should not be used with an albuterol inhalation aerosol canister. the refill canister is to be used only with the blue albuterol inhalation aerosol adapter id#720. - 1.shake the inhaler well immed

Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg in 5 ml - albuterol sulfate syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. albuterol sulfate syrup is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. safety and effectiveness in children below 2 years of age have not been established.

Bandaríkin - enska - NLM (National Library of Medicine)

actavis pharma, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg in 5 ml - albuterol sulfate syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. albuterol sulfate syrup is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. safety and effectiveness in children below 2 years of age have not been established.

Bandaríkin - enska - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

nephron pharmaceuticals corporation - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 0.5 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

bryant ranch prepack - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 4 mg - albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease. albuterol tablets are contraindicated in patients with a history of hypersensitivity to albuterol, or any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. albuterol sulfate inhalation solution 0.083% 3 note: this is a unit-dose vial. no dilution is required. read complete instructions carefully before using. note: use only as directed by your physician. more frequent administration or higher doses are not recommended . store albuterol sulfate inhalation solution 0.083%3 between 2° and 25° c (36° and 77° f). store in pouch until time of use. additional instructions: ___________________________________________ ________________________________________________________________________ ________________________________________________________________________ manufactured for: mylan pharmaceuticals inc. morgantown, wv 26505 manufactured by:

Bandaríkin - enska - NLM (National Library of Medicine)

sandoz inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components.

Bandaríkin - enska - NLM (National Library of Medicine)

ritedose pharmaceuticals, llc - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. albuterol sulfate inhalation solution 0.083% 3 note: this is a unit-dose vial. no dilution is required. read complete instructions carefully before using. - remove the vial from the foil pouch. - twist the cap completely off the vial and squeeze the contents into the nebulizer reservoir (figure 1). - connect the nebulizer reservoir to the mouthpiece or face mask (figure 2). - connect the nebulizer to the compressor. - sit in a comfortable, upright position; place the mouthpiece in your mouth (figure 3) (or put on the face mask); and turn on the compressor. - breathe as calmly, deeply and evenly as possible until no more mist is formed in the nebulizer chamber (about 5 to 15 minutes). at this point, the treatment is finished. - clean the nebulizer (see manufacturer's instructions). note: use only as directed by your physician. more frequent administration or higher doses are not recommended . store albuterol sulfate inhalation solution 0.083% 3 between 2° and 25° c (36° and 77° f). store in pouch until time of use. additional instructions: manufactured by: the ritedose corporation columbia, sc 29203 for ritedose pharmaceuticals, llc columbia, sc 29203 to report suspected adverse reactions, contact ritedose pharmaceuticals, llc at 1-855-806-3300 or fda at 1-800-fda-1088 or www.fda.gov/medwatch rpin0052 march 2014